Overview: AI-powered CGMs could predict glucose changes before they occur, enabling smarter, more proactive diabetes management.Future sensors may become smalle ...
MultiDimension Technology Co., Ltd. (MDT), a leading supplier of magnetic sensors and a pioneer in Tunneling ...
Vital Signals has launched Signal Ring, the first wearable ring designed specifically for continuous, calibration-free blood ...
By Siddhi Mahatole July 16 (Reuters) - Abbott beat estimates for quarterly results and raised its annual profit forecast on ...
Wall Street still prices Abbott like a dividend stalwart, but overlooked moves suggest that framing may be costing investors ...
Zacks Investment Research on MSN
DXCM secures Health Canada authorization for Dexcom G7 15 day CGM
DexCom DXCM recently announced that the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System has received ...
Health Canada has granted authorisation for the Dexcom G7 15 Day continuous glucose monitor (CGM) for adults aged 18 years ...
Healthy influencers are embracing a wearable once reserved for diabetes patients to optimize their health. But experts say ...
(NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
Abbott (ABT) outpaced Danaher (DHR) as FreeStyle Libre delivered $2.08B while Cepheid respiratory revenue fell 25% on a soft flu season. Danaher's bioprocessing equipment orders surged over 30%, ...
Continuous glucose monitoring is associated with improved survival among patients with diabetes who are receiving dialysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results